Tandem and JDRF Agreement for Dual Hormone Pump

Tandem and JDRF have entered into an agreement to develop a dual hormone pump.

SAN DIEGO, Jan. 8, 2013 /PRNewswire via COMTEX/ -- Tandem Diabetes Care, Inc. ("Tandem") announced today a partnership with JDRF, the leading global organization focused on type 1 diabetes (T1D) research, to develop a first-of-its-kind, dual-chamber infusion pump for the management of diabetes. The partnership agreement is designed to accelerate the development of a next-generation, fully automated artificial pancreas system using therapies in conjunction with insulin.

Looks a lot like a JDRF IDDP. Has all the right words, performance based milestones etc, just not the IDDP letter.  Full test here:

http://www.marketwatch.com/story/tandem-diabetes-care-announces-partnership-with-jdrf-to-develop-a-novel-dual-chamber-infusion-pump-2013-01-08